Company: ARWR
Filing Date: 2025-01-29
Form Type: ARS
Source: 0001628280-25-002866
Chunk: 151

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-01-29
Form: ARS
Chunk 151
---
otes 2 Deadline for Receipt of Stockholder Proposals 3 Proposal One — Election of Directors 4 Board Composition and Nominating Process 12 Corporate Governance, Environmental and Social Commitment 14 Stockholder Communications with Directors 15 Board Meetings and Committees 15 Director Compensation 18 Proposal Two — Advisory Vote to Approve Executive Compensation 20 Proposal Three — Advisory Vote on Frequency of Executive Compensation Advisory Votes 21 Executive Compensation 22 Compensation Discussion and Analysis 22 Our Company 22 Business Development 23 Platform 24 Pipeline 25 Executive Compensation Philosophy 33 Executive Compensation Program Design 33 Governance of Executive Compensation Program 34 Individual Compensation Elements 36 Employment Arrangements 41 Post-Employment Compensation Arrangements 41 Other Compensation Policies and Practices 41 Tax and Accounting Considerations 42 Compensation Risk Assessment 43 Compensation Tables 44 Proposal Four — Ratification of Appointment of Independent Auditors 58 Audit Fees 59 Report of the Audit Committee 60 Voting Securities of Principal Stockholders and Management 61 Equity Compensation Plan Information 63 Review and Approval of Related-Party Transactions 65 Certain Relationships and Related Transactions, and Director Independence 66 Table of Contents 2025 PROXY STATEMENT Table of Contents

ARROWHEAD PHARMACEUTICALS, INC. 177 E. Colorado Blvd., Suite 700 Pasadena, California 91105 (626) 304-3400 PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS To be held on Wednesday, March 12, 2025 General Information Concerning Solicitation and Voting The enclosed Proxy is solicited on behalf of Arrowhead Pharmaceuticals, Inc. (the “Company” or “Arrowhead”) for use at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) to be held on Wednesday, March 12, 2025 at 10:00 a.m., Pacific time, and at any adjournment(s) or postponement(s) thereof, for the purposes set forth herein and in the accompanying Notice of Annual Meeting of Stockholders (the “Notice”). The Company anticipates that the Notice Regarding the Availability of Proxy Materials (the “Notice of Internet Availability”) in connection with these proxy solicitation materials will first be mailed on or about January 28, 2024 to all stockholders entitled to vote at the Annual Meeting and we will post our proxy materials on the website referenced in the Notice of Internet Availability. As more fully described in the Notice of Internet Availability, all stockholders may choose to access our proxy